Sort
21,453 grants matching “tuberculosis”
Technology Core
$794,278Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2016 · AI
Inhaled tigecycline therapy for pulmonary M. abscessus infections
$794,098Mercedes Gonzalez-Juarrero · Colorado State University · R01 · FY2022 · AI
Capturing spatial patterns of new M. tuberculosis infection in Kampala, Uganda
$793,932Charles Martyn Bark · Case Western Reserve University · R01 · FY2024 · AI
Task 6: Technical Support for Tuberculosis Therapeutics
$793,906Norman Kneteman · Sri International · N01 · FY2013 · AI
Novel mycobacterial translocase I inhibitors - a new class of anti-TB drugs
$793,901Venkata M Reddy · Sequella, Inc. · R44 · FY2008 · AI
Preclinical modeling to study Tuberculous Meningitis
$793,509Sanjay Jain · Johns Hopkins University · R01 · FY2022 · AI
Identifying TB transmitters in high TB/HIV burdened communities
$793,399Robin Wood · Desmond Tutu Hiv Foundation · R01 · FY2020 · AI
The effect of HIV exposure and infection on immunity to TB in children
$793,352Grace C John-Stewart · University Of Washington · R01 · FY2020 · AI
Handheld and population-based sequencing for rapid detection of new and repurposed drug resistance in M. tuberculosis
$793,285John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2021 · AI
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
$793,149Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Human immune signatures of natural immunity to DENV infection, severe disease, and vaccination with attenuated live vaccine
$793,148Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2017 · AI
Dual Targeting of Mtb Resistance Mechanisms
$792,965Christoph Grundner · Seattle Children'S Hospital · R01 · FY2024 · AI
TUBERCULOSIS CONTROL AND ELIMINATION IN THE STATE OF HAWAII
$792,877Chiyome L Fukino · Hawaii State Department Of Health · U52 · FY2010 · PS
Safe Pregnancy by Infectious Disease Control in Kinshasa
$792,697University Of North Carolina Chapel Hill · U01 · FY2004 · HD
Adjuvants for Skin Immunization: Discovery and Mechanisms
$792,636Ioanna Skountzou · Emory University · R01 · FY2015 · AI
Preventing TB with intravenous BCG in SIV-infected macaques
$792,599Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Microbial induction of sarcoidosis CD4+ T cell dysfunction
$792,506Wonder P. Drake · Vanderbilt University Medical Center · R01 · FY2017 · HL
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
$792,488Scott K Heysell · University Of Virginia · R01 · FY2020 · AI
Novel delivery platform and antigen design for an effective COVID-19 vaccine
$792,476Suresh K Mittal · Purdue University · R01 · FY2020 · AI
Development of novel penems for drug-resistant tuberculosis
$792,429Craig A Townsend · Johns Hopkins University · R01 · FY2019 · AI
Project 2: Essential metabolic objectives of M. tuberculosis aerobiology
$792,016Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$792,012Frederick Lewis Altice · Yale University · R01 · FY2021 · DA
Target based discovery of next generation pyrazinamide
$791,696Thomas Dick · Hackensack University Medical Center · R01 · FY2022 · AI
Disease Modifying Biologics for Rheumatoid Arthritis
$791,681Rekha Bansal · Novelmed Therapeutics, Inc. · R44 · FY2010 · AG
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$791,431Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2023 · AI